Management of multivessel coronary artery disease

P B Parikh1, A J Kirtane, J W Moses

  • 1Division of Cardiology, Department of Medicine Columbia University Medical Center/New YorkPresbyterian Hospital, New York, NY, USA - jm2456@columbia.edu.

Panminerva Medica
|January 18, 2014
PubMed

Insights

Optimal management of multivessel disease (MVD) requires individualized treatment plans. Decisions involve percutaneous coronary intervention, bypass surgery, or medical therapy, guided by patient factors and disease severity.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiovascular Medicine

Background:

  • Multivessel disease (MVD) management is complex, impacting patient prognosis.
  • Clinical and angiographic scores aid treatment decisions but individualization is key.
  • Choosing between revascularization (PCI/CABG) and guideline-directed medical therapy (GDMT) is critical.

Purpose of the Study:

  • To review optimal management strategies for multivessel coronary artery disease.
  • To discuss factors influencing the choice between revascularization and medical therapy.
  • To explore various aspects of MVD treatment, including revascularization extent and guidance strategies.

Main Methods:

  • Review of current literature and clinical guidelines on MVD management.
  • Analysis of patient-specific factors influencing treatment decisions.
  • Discussion of comparative outcomes for different revascularization strategies.

Main Results:

  • Individualized patient assessment is paramount in MVD management.
  • Treatment selection (PCI, CABG, GDMT) depends on clinical presentation, disease severity, and patient preference.
  • Strategies include complete vs. incomplete revascularization and angiography- vs. ischemia-guided approaches.

Conclusions:

  • Optimal MVD management necessitates a personalized approach integrating clinical, angiographic, and patient factors.
  • The choice of revascularization modality and extent significantly influences outcomes.
  • Guideline-directed medical therapy remains a crucial component, especially when revascularization is not indicated or feasible.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
444
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
741
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
493
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
522
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
890
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
611